Pharmafile Logo

XDx

- PMLiVE

FDA approves Novartis’ next-gen MS drug Mayzent

Drug reduces risk of disease progression

Leading Edge, a Lucid Group company, strengthens its senior client services team

Leading Edge, a Lucid Group company, is delighted to announce the appointment of its new Lead Client Partnership Director, Frances O’Connor.Frances is an experienced strategic healthcare communicator with expertise in...

Lucid Group Communications Limited

- PMLiVE

New faces at 11 London, ramarketing and MSL

Latest movers in healthcare comms

- PMLiVE

Francis exits Sandoz, reigniting spinoff rumours

Novartis says no such plans at present

- PMLiVE

Novartis back in the spotlight over Trump/Cohen links

Cohen said the fee intended to get him to work as a lobbyist

- PMLiVE

Streaming Well to “raise the bar in pharma film making”

Company appoints Steve Skinner and Freddie Slaughter to further its goal

- PMLiVE

Novartis in-licenses Akcea’s novel cardiovascular therapy

Lp(a) targeting therapy could treat millions

- PMLiVE

Greater Manchester backs move to outcome-based payment

Region teams up with Cancer Research UK to accelerate change

Lighthouse Medical Communications US appoints Lisa Druce as its new Managing Partner

Lighthouse Medical Communications US, a Lucid Group company, is delighted to announce the appointment of its new Managing Partner, Lisa Druce.Lisa is an experienced strategic business leader and healthcare communications...

Lucid Group Communications Limited

- PMLiVE

FCB Health’s Neon attracts new managing director

Mardene Miller will lead the agency with co-managing director Kevin McHale

- PMLiVE

Novartis’ Egatan gains US approval for neglected tropical disease

US approval removes barrier to greater access

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links